Haifeng Wang

597 total citations · 1 hit paper
43 papers, 357 citations indexed

About

Haifeng Wang is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Haifeng Wang has authored 43 papers receiving a total of 357 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Surgery, 18 papers in Pulmonary and Respiratory Medicine and 13 papers in Molecular Biology. Recurrent topics in Haifeng Wang's work include Bladder and Urothelial Cancer Treatments (17 papers), Ferroptosis and cancer prognosis (6 papers) and Epigenetics and DNA Methylation (6 papers). Haifeng Wang is often cited by papers focused on Bladder and Urothelial Cancer Treatments (17 papers), Ferroptosis and cancer prognosis (6 papers) and Epigenetics and DNA Methylation (6 papers). Haifeng Wang collaborates with scholars based in China and United States. Haifeng Wang's co-authors include Shi Fu, Xiaorong Chen, Jiansong Wang, Zhao Yang, Suyun Li, Jiansheng Li, Xueqing Yu, Song Wu, Chong Li and Zusen Fan and has published in prestigious journals such as PLoS ONE, Gene and Journal of Ethnopharmacology.

In The Last Decade

Haifeng Wang

33 papers receiving 352 citations

Hit Papers

Comprehensive analysis of scRNA-Seq and bulk RNA-Seq reve... 2023 2026 2024 2025 2023 25 50 75
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Comprehensive analysis of scRNA-Seq and bulk RNA-Seq reveals dynamic changes in the tumor immune microenvironment of bladder cancer and establishes a prognostic model
    2023 89 citations Xiaorong Chen, Shi Fu et al. Journal of Translational Medicine profile →

Peers

Haifeng Wang
Shijun Tong China
Chung‐Chieh Wang Taiwan
Katharina Sinn Austria
Zhenqiang Gao China
Yue Shao China
Mridula Shukla India
Yunfei Feng China
Pengcheng Luo China
Hua Pang China
Shijun Tong China
Haifeng Wang
Citations per year, relative to Haifeng Wang Haifeng Wang (= 1×) peers Shijun Tong

Countries citing papers authored by Haifeng Wang

Since Specialization
Citations

This map shows the geographic impact of Haifeng Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haifeng Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haifeng Wang more than expected).

Fields of papers citing papers by Haifeng Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haifeng Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haifeng Wang. The network helps show where Haifeng Wang may publish in the future.

Co-authorship network of co-authors of Haifeng Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Haifeng Wang. A scholar is included among the top collaborators of Haifeng Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haifeng Wang. Haifeng Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
He, Lingfeng, et al.. (2025). mpECs with high Piezo2 expression promote fracture healing by driving angiogenesis through the Notch signaling pathway. BMC Musculoskeletal Disorders. 26(1). 238–238. 1 indexed citations
2.
Shang, Shunlai, Guo‐Wei He, Jian Zhang, et al.. (2025). Advances in precision medicine for lupus nephritis: biomarker- and AI-driven diagnosis and treatment response prediction and targeted therapies. EBioMedicine. 117. 105785–105785. 2 indexed citations
3.
Li, Ji, et al.. (2024). Unilateral adrenal Castleman's disease: A case report. Urology Case Reports. 57. 102849–102849.
4.
Li, Yang, et al.. (2024). A Silent Threat: Deep Vein Thrombosis in Early-Stage Parkinson’s Disease. Risk Management and Healthcare Policy. Volume 17. 2169–2179. 1 indexed citations
5.
Wang, Haifeng, et al.. (2024). Engineering VEGF-like peptide QKCMP promotes rapid endothelialization of blood vessels. Journal of Applied Biomaterials & Functional Materials. 22. 1617655484–1617655484.
6.
Fu, Shi, Zhi‐Yong Tan, Junhao Chen, et al.. (2024). Development of a stemness-related prognostic index to provide therapeutic strategies for bladder cancer. npj Precision Oncology. 8(1). 14–14. 9 indexed citations
7.
8.
Zhang, Yifei, et al.. (2024). Nano-Bacillus Calmette-Guérin immunotherapies for improved bladder cancer treatment. Journal of Zhejiang University SCIENCE B. 25(7). 557–567. 5 indexed citations
9.
Chen, Xiaorong, et al.. (2024). HES4 is a potential biomarker for bladder cancer: a Mendelian randomization study. Journal of Cancer. 15(6). 1624–1641. 2 indexed citations
10.
Chen, Xiaorong, et al.. (2023). Comprehensive analysis of scRNA-Seq and bulk RNA-Seq reveals dynamic changes in the tumor immune microenvironment of bladder cancer and establishes a prognostic model. Journal of Translational Medicine. 21(1). 223–223. 89 indexed citations breakdown →
11.
12.
Chen, Yuan, et al.. (2022). Renal cancer associated with Xp11.2 translocation/TFE3 gene fusion: Clinicopathological analysis of 13 cases. Annals of Diagnostic Pathology. 58. 151908–151908. 5 indexed citations
13.
Yang, Zhao, Yinyan Xu, Ying Bi, et al.. (2021). Immune escape mechanisms and immunotherapy of urothelial bladder cancer. Journal of Clinical and Translational Research. 7(4). 485–500. 22 indexed citations
14.
Jiang, Qi, Tao Tao, Xing Kang, et al.. (2019). Hope and challenge: Precision medicine in bladder cancer. Cancer Medicine. 8(4). 1806–1816. 35 indexed citations
15.
Qu, Min, Haifeng Wang, Linhui Wang, et al.. (2017). Robotic-assisted laparoscopic prostatectomy in patients with high-risk prostate cancer: experiences of 400 cases. Zhonghua miniao waike zazhi. 38(6). 424–427.
16.
Wang, Haifeng, Daming Wang, Lijun Wang, et al.. (2017). Extracranial Internal Carotid Artery Tortuosity and Body Mass Index. Frontiers in Neurology. 8. 508–508. 30 indexed citations
17.
Li, Jiansheng, Haifeng Wang, Suyun Li, et al.. (2016). Effect of sequential treatment with TCM syndrome differentiation on acute exacerbation of chronic obstructive pulmonary disease and AECOPD risk window. Complementary Therapies in Medicine. 29. 109–115. 15 indexed citations
18.
Wang, Haifeng & Jiansong Wang. (2012). Research Progress in Potential Urinary Markers for the Early Detection, Diagnosis and Follow-up of Human Bladder Cancer. Asian Pacific Journal of Cancer Prevention. 13(5). 1723–1726. 10 indexed citations
19.
Li, Jiansheng, et al.. (2011). Shenmai Injection for Chronic Pulmonary Heart Disease: A Systematic Review and Meta-Analysis. The Journal of Alternative and Complementary Medicine. 17(7). 579–587. 24 indexed citations
20.
Wang, Haifeng. (2009). Assessment of the nutritional status and quality of life of the elderly patients with malignant tumor by MNA-SF and SF-36. Journal of Tongji University. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shijun Tong Breakdown of academic impact, for papers by Chung‐Chieh Wang Breakdown of academic impact, for papers by Katharina Sinn Breakdown of academic impact, for papers by Zhenqiang Gao Breakdown of academic impact, for papers by Yue Shao Breakdown of academic impact, for papers by Mridula Shukla Breakdown of academic impact, for papers by Yunfei Feng Breakdown of academic impact, for papers by Pengcheng Luo Breakdown of academic impact, for papers by Hua Pang
Rankless by CCL
2026